Verastem, Inc. (NASDAQ:VSTM) Receives $13.63 Consensus PT from Brokerages
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in […]
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in […]
